Sleep Duration, Lifestyle Intervention, and Incidence of Type 2 Diabetes in Impaired Glucose Tolerance

OBJECTIVE Both short and long sleep duration have frequently been found to be associated with an increased risk for diabetes. The aim of the present exploratory analysis was to examine the association between sleep duration and type 2 diabetes after lifestyle intervention in overweight individuals with impaired glucose tolerance in a 7-year prospective follow-up. RESEARCH DESIGN AND METHODS A total of 522 individuals (aged 40–64 years) were randomly allocated either to an intensive diet-exercise counseling group or to a control group. Diabetes incidence during follow-up was calculated according to sleep duration at baseline. Sleep duration was obtained for a 24-h period. Physical activity, dietary intakes, body weight, and immune mediators (C-reactive protein and interleukin-6) were measured. RESULTS Interaction between sleep duration and treatment group was statistically significant (P = 0.003). In the control group, the adjusted hazard ratios (HRs) (95% CI) for diabetes were 2.29 (1.38–3.80) and 2.74 (1.67–4.50) in the sleep duration groups 9–9.5 h and ≥10 h, respectively, compared with for that of the 7–8.5 h group. In contrast, sleep duration did not influence the incidence of diabetes in the intervention group; for sleep duration groups 9–9.5 h and ≥10 h, the adjusted HRs (95% CI) were 1.10 (0.60–2.01) and 0.73 (0.34–1.56), respectively, compared with that in the reference group (7–8.5 h sleep). Lifestyle intervention resulted in similar improvement in body weight, insulin sensitivity, and immune mediator levels regardless of sleep duration. CONCLUSIONS Long sleep duration is associated with increased type 2 diabetes risk. Lifestyle intervention with the aim of weight reduction, healthy diet, and increased physical activity may ameliorate some of this excess risk.

[1]  Mark C. Jones PRINCIPLES AND PRACTICE OF SLEEP MEDICINE , 1990 .

[2]  T. Lakka,et al.  Intra-person variability of various physical activity assessments in the Kuopio Ischaemic Heart Disease Risk Factor Study. , 1992, International journal of epidemiology.

[3]  C. Dolea,et al.  World Health Organization , 1949, International Organization.

[4]  K. Spiegel,et al.  Impact of sleep debt on metabolic and endocrine function , 1999, The Lancet.

[5]  V. Vaccarino,et al.  Depressive Symptoms and Metabolic Syndrome: Is Inflammation the Underlying Link? , 2008, Biological Psychiatry.

[6]  T. Valle,et al.  Systemic Immune Mediators and Lifestyle Changes in the Prevention of Type 2 Diabetes , 2006, Diabetes.

[7]  F. Hu,et al.  Correlates of long sleep duration. , 2006, Sleep.

[8]  R. Stafford,et al.  Principles and Practice of Sleep Medicine , 2001 .

[9]  D. Skene,et al.  Comparison between subjective and actigraphic measurement of sleep and sleep rhythms , 1999, Journal of sleep research.

[10]  T. Young,et al.  Risk factors for obstructive sleep apnea in adults. , 2004, JAMA.

[11]  J. Manson,et al.  A prospective study of self-reported sleep duration and incident diabetes in women. , 2003, Diabetes care.

[12]  D. Kripke,et al.  Mortality associated with sleep duration and insomnia. , 2002, Archives of general psychiatry.

[13]  H. Yaggi,et al.  Sleep duration as a risk factor for the development of type 2 diabetes. , 2006, Diabetes care.

[14]  K. Lam,et al.  Obstructive sleep apnea is independently associated with insulin resistance. , 2002, American journal of respiratory and critical care medicine.

[15]  T. Valle,et al.  Anti-inflammatory effect of lifestyle changes in the Finnish Diabetes Prevention Study , 2009, Diabetologia.

[16]  D. Papanicolaou,et al.  Elevation of plasma cytokines in disorders of excessive daytime sleepiness: role of sleep disturbance and obesity. , 1997, The Journal of clinical endocrinology and metabolism.

[17]  J. Tuomilehto,et al.  Sleep duration is associated with an increased risk for the prevalence of type 2 diabetes in middle-aged women - The FIN-D2D survey. , 2008, Sleep medicine.

[18]  J. Tuomilehto,et al.  Lifestyle intervention with weight reduction: first-line treatment in mild obstructive sleep apnea. , 2009, American journal of respiratory and critical care medicine.

[19]  J. Lindström,et al.  Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study , 2006, The Lancet.

[20]  Mikko Härmä,et al.  Self‐reported sleep duration in Finnish general population , 2006, Journal of sleep research.

[21]  S. Drummond,et al.  Who are the long sleepers? Towards an understanding of the mortality relationship. , 2007, Sleep medicine reviews.

[22]  J. Tuomilehto,et al.  Long-term improvement in insulin sensitivity by changing lifestyles of people with impaired glucose tolerance: 4-year results from the Finnish Diabetes Prevention Study. , 2003, Diabetes.

[23]  Jaakko Tuomilehto,et al.  The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity. , 2003, Diabetes care.